Cardlytics, Inc. reported significant financial challenges in its latest 10-Q filing for the quarter ending September 30, 2024. The company experienced a notable decline in revenue, with total revenue for the three months amounting to $67.1 million, down 15% from $79.0 million in the same period of 2023. For the nine months ended September 30, 2024, revenue decreased by 7.2% to $204.3 million compared to $220.0 million in the prior year. The decline was attributed to reduced sales from existing marketers, despite an increase in sales to new marketers.
The company's total costs and expenses surged to $215.6 million for the third quarter, compared to $99.7 million in the same quarter of 2023. This increase was primarily driven by a substantial impairment of goodwill and intangible assets amounting to $131.6 million, which significantly impacted profitability. As a result, Cardlytics reported an operating loss of $148.5 million for the three months ended September 30, 2024, compared to a loss of $20.7 million in the same period last year. The net loss for the quarter was $145.2 million, a stark increase from $24.0 million in the prior year.
For the nine-month period, the net loss escalated to $173.7 million, compared to $33.9 million in the same period of 2023. The company’s accumulated deficit reached $1.3 billion as of September 30, 2024. The increase in net loss was partly due to a rise in consumer incentives, which increased by $21.8 million, reflecting higher customer engagement.
In terms of strategic developments, Cardlytics issued $172.5 million in Convertible Senior Notes in April 2024, with proceeds used to repurchase a portion of its existing debt. The company also completed an equity distribution agreement, raising $48.3 million through the sale of shares. Additionally, Cardlytics sold assets related to HSP EPI Acquisition, LLC for $6.0 million in December 2023.
The company’s cash and cash equivalents decreased to $67.0 million as of September 30, 2024, down from $91.8 million at the end of 2023. Despite these challenges, Cardlytics maintains that it has sufficient liquidity to fund operations for at least the next 12 months. The company continues to focus on expanding its advertising platform and enhancing relationships with financial institution partners, which are critical for its revenue generation.
About Cardlytics, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.